Integrative Oncology in Supportive Cancer Care in Israel
- PMID: 29607685
- PMCID: PMC6142087
- DOI: 10.1177/1534735418764839
Integrative Oncology in Supportive Cancer Care in Israel
Abstract
Purpose: Integrative oncology (IO) services provide complementary/integrative medicine (CIM) therapies to patients as part of their supportive cancer care. In this study, we examine and compare the structural, operational, financial and academic/research-related aspects of IO services in Israeli oncology centers.
Methods: The medical directors of seven Israeli IO programs completed questionnaires which explored the objectives and organizational features of their service within the context of supportive cancer care.
Results: All participating IO services addressed patient-reported concerns related to quality of life and function, within the context of conventional supportive cancer care. The centers shared similar characteristics regarding the procedure of referral to their service and emphasized research and teaching initiatives within an academic framework, as part of their clinical practice. A number of obstacles to integration were identified, primarily those related to financial considerations, such as the need for patients to carry the cost of the CIM treatments.
Conclusions: IO services situated within conventional oncology departments in Israel share a number of characteristics, as well as obstacles to their incorporation into standard care. All participating centers described both clinical and academic activities, including research initiatives and the promotion of CIM in an academic setting. Further research is needed in order to better understand the place of CIM in the oncology setting and prioritize the allocation of resources in order to advance the inclusion of CIM in standard supportive cancer care.
Keywords: Israel; cancer care; complementary medicine; integrative oncology; supportive care.
Conflict of interest statement
Similar articles
-
Attitudes Among Nurses Toward the Integration of Complementary Medicine Into Supportive Cancer Care.Oncol Nurs Forum. 2017 Jul 1;44(4):428-434. doi: 10.1188/17.ONF.428-434. Oncol Nurs Forum. 2017. PMID: 28632238
-
Integrative Medicine: Adjunctive Element or Essential Ingredient in Palliative and Supportive Cancer Care?J Altern Complement Med. 2020 Sep;26(9):779-783. doi: 10.1089/acm.2019.0316. J Altern Complement Med. 2020. PMID: 32924563
-
Crossing the death threshold: experiencing multi-disciplinary end-of-life integrative oncology training.Support Care Cancer. 2018 Jul;26(7):2251-2257. doi: 10.1007/s00520-018-4068-6. Epub 2018 Feb 1. Support Care Cancer. 2018. PMID: 29392483
-
Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey.BMC Complement Altern Med. 2018 Oct 29;18(1):289. doi: 10.1186/s12906-018-2357-8. BMC Complement Altern Med. 2018. PMID: 30373631 Free PMC article.
-
Integrative Medicine for Ovarian Cancer.Curr Oncol Rep. 2023 Jun;25(6):559-568. doi: 10.1007/s11912-023-01359-8. Epub 2023 Mar 20. Curr Oncol Rep. 2023. PMID: 36939963 Review.
Cited by
-
Acupuncture in obstetrics: delivery room integrative medicine for anxiety and pain.BMJ Support Palliat Care. 2025 Jun 27;15(4):535-541. doi: 10.1136/spcare-2025-005512. BMJ Support Palliat Care. 2025. PMID: 40240122 Free PMC article.
-
Impact of Systematic Holistic Nursing Combined with Narrative Nursing Intervention for Patients with Advanced Gastric Cancer on Complications and Negative Emotions.Evid Based Complement Alternat Med. 2022 Jul 15;2022:9148843. doi: 10.1155/2022/9148843. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 6;2023:9796824. doi: 10.1155/2023/9796824. PMID: 35873642 Free PMC article. Retracted.
-
Integrative Oncology: An International Perspective from Six Countries.Integr Cancer Ther. 2021 Jan-Dec;20:15347354211004730. doi: 10.1177/15347354211004730. Integr Cancer Ther. 2021. PMID: 33784850 Free PMC article.
-
Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management.Cancers (Basel). 2020 Oct 23;12(11):3096. doi: 10.3390/cancers12113096. Cancers (Basel). 2020. PMID: 33114159 Free PMC article. Review.
-
Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis.Cancers (Basel). 2024 Sep 11;16(18):3130. doi: 10.3390/cancers16183130. Cancers (Basel). 2024. PMID: 39335102 Free PMC article. Review.
References
-
- Deng GE, Frenkel M, Cohen L, et al. ; Society for Integrative Oncology. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7:85-120. - PubMed
-
- Shmueli A, Igudin I, Shuval J. Change and stability: use of complementary and alternative medicine in Israel: 1993, 2000 and 2007. Eur J Public Health. 2011;21:254-259. - PubMed
-
- Frenkel M. Integrative medicine in Israel: system supports better access to complementary therapies. Altern Complement Ther. 2014;20:123-125.
-
- The Israel Society for Complementary Medicine. About the society. http://www.cam.org.il/inner.asp?page=English. Accessed February 27, 2018.
-
- Caspi O. Do’s and don’ts in the establishment of an integrative medicine service in the public health care system—challenges and insights [in Hebrew]. Harefuah. 2015;154:187-191,211,210. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical